Pharmageddon USA is a 2-day innovation experience designed to reframe thinking from what pharma is to what it could be. They’ve thrown out drawn-out vendor presentations and predictable press readings and replaced them with Ted-talk style case studies and provocative panels.
Join TransCelerate BioPharma CEO Janice Chang and Cristian Massacesi (AstraZeneca) for the panel “Patient Disruption.” At this event, learn how to achieve action at the same time as democratizing patient engagement throughout the company, whilst also valuing and measuring patient engagement ROI by understanding and articulating the value of true partnership with patients.